Guilin Sanjin Pharmaceutical Co.,Ltd — Investor Relations & Filings
Guilin Sanjin Pharmaceutical Co.,Ltd. specializes in the research, development, and manufacturing of proprietary Chinese medicines and natural health products. The company is recognized for its integration of traditional herbal formulas with modern pharmaceutical technology. Its core product portfolio includes the Sanjin Tablet series, primarily used for treating urinary tract infections, and the Guilin Watermelon Frost series, widely utilized for oral and throat ailments. The firm operates advanced production facilities and maintains a strong focus on innovation within the field of modern Traditional Chinese Medicine (TCM). Its product range extends to various therapeutic areas, including cardiovascular health and internal medicine, catering to both domestic and international markets through a commitment to quality and standardized production processes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于为孙公司提供担保的进展公告 | 2026-03-27 | Chinese | |
| 关于为孙公司提供担保的进展公告 | 2026-02-27 | Chinese | |
| 北京市通商律师事务所关于桂林三金药业股份有限公司2025年第二次临时股东大会的法律意见书 | 2025-12-26 | Chinese | |
| 第九届董事会第一次会议决议公告 | 2025-12-26 | Chinese | |
| 2025年第二次临时股东大会决议公告 | 2025-12-26 | Chinese | |
| 关于董事会完成换届选举暨聘任高级管理人员、证券事务代表的公告 | 2025-12-26 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
2 filings
| |||||
| 35247821 | 关于为孙公司提供担保的进展公告 | 2026-03-27 | Chinese | ||
| 35247817 | 关于为孙公司提供担保的进展公告 | 2026-02-27 | Chinese | ||
|
2025
13 filings
| |||||
| 35247814 | 北京市通商律师事务所关于桂林三金药业股份有限公司2025年第二次临时股东大会的法律意见书 | 2025-12-26 | Chinese | ||
| 35247811 | 第九届董事会第一次会议决议公告 | 2025-12-26 | Chinese | ||
| 35247807 | 2025年第二次临时股东大会决议公告 | 2025-12-26 | Chinese | ||
| 35247805 | 关于董事会完成换届选举暨聘任高级管理人员、证券事务代表的公告 | 2025-12-26 | Chinese | ||
| 35247802 | 关于选举职工董事的公告 | 2025-12-23 | Chinese | ||
| 36129566 | 互动易平台信息发布及回复内部审核制度（2025年12月） | 2025-12-10 | Chinese | ||
| 36129564 | 对外提供财务资助管理制度（2025年12月） | 2025-12-10 | Chinese | ||
| 36129563 | 会计师事务所选聘制度（2025年12月） | 2025-12-10 | Chinese | ||
| 36129559 | 总裁工作管理制度（2025年12月） | 2025-12-10 | Chinese | ||
| 36129551 | 防止控股股东、实际控制人及关联方占用公司资金的管理制度（2025年12月） | 2025-12-10 | Chinese | ||
| 36129546 | 投资者关系管理制度（2025年12月） | 2025-12-10 | Chinese | ||
| 36129545 | 重大信息内部报告制度（2025年12月） | 2025-12-10 | Chinese | ||
| 36129540 | 关于为全资子公司提供担保的公告 | 2025-12-10 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Guilin Sanjin Pharmaceutical Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54326/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54326 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54326 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54326 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54326}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Guilin Sanjin Pharmaceutical Co.,Ltd (id: 54326)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.